Recent findings by He et al. highlighted frequent low expression levels of methionine sulfoxide reductase A (MSRA), a reducing enzyme of oxidized methionine residue, in metastatic tumor tissues of patients with PDAC. Here, MSRA is linked to metastatic neoplasm.